CTI Life Sciences Fund raises $100 million in first close of third venture fund Montréal-based venture capital firm CTI Life Sciences Fund has raised $100 million CAD in the first close of its third venture fund. The fund’s limited partners include previous investors such as Fonds de solidarité FTQ, Caisse de dépôt et placement du Québec, Investissement Québec and Teralys Capital. Other investors include BDC Capital’s fund investments team. BDC Capital also invested in CTI’s second fund through the federal government’s Venture Capital Action Plan (VCAP). “Never has the life sciences industry been more critical to the health of both people and economies around the world.”